Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis

(2019) Kiyomi Shinohara et al.   BMJ Open

Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression

(2015) Ross J. Baldessarini et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Meta-analysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants

(2015) Richard Hansen et al.   PSYCHIATRIC SERVICES

Review of Maintenance Trials for Major Depressive Disorder

(2014) Silvana Borges et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder

(2013) Joshua Z. Rosenthal et al.   JOURNAL OF CLINICAL PSYCHIATRY

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

(2012) Guy M. Goodwin et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

(2012) Mark Zimmerman et al.   JOURNAL OF CLINICAL PSYCHIATRY

A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder

(2012) Jean-Philippe Boulenger et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression

(2010) Zindel V. Segal et al.   ARCHIVES OF GENERAL PSYCHIATRY

Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

(2010) Paul Glue et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder

(2010) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Relapse rates with long-term antidepressant drug therapy: a meta-analysis

(2009) Nolan Williams et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome

(2009) Guy M. Goodwin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Duloxetine in the Prevention of Depressive Recurrences

(2009) David G. S. Perahia et al.   JOURNAL OF CLINICAL PSYCHIATRY

Course and outcome of depressive disorders in primary care: a prospective 18-month study

(2009) M. S. Vuorilehto et al.   PSYCHOLOGICAL MEDICINE

Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents

(2008) G. J. Emslie et al.   AMERICAN JOURNAL OF PSYCHIATRY

Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials

(2008) D. Deshauer et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Maintenance Study for Adolescent Depression

(2008) Amy Cheung et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY